{"title":"[Obesity, type 2 diabetes, metabolic syndrome and depression : a two-way relationship].","authors":"André Scheen","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Metabolic disorders, especially obesity, type 2 diabetes and metabolic syndrome, are frequently associated with depressive symptomatology, including severe depression. In fact, there is a two-way relationship : metabolic disorders could promote depression and depression could favour metabolic disorders, which may lead to a vicious circle. The reasons for this astonishing relationship are diverse : a genetic predisposition, shared biochemical abnormalities including low-grade inflammation, bad habits that combine unhealthy food and excessive sedentary life-style, poor therapeutic compliance. Medications that target metabolic disorders may positively impact depression, with recent promising, yet preliminary, data with glucagon-like peptide-1 receptor agonists. Moreover, antidepressants may also influence metabolic disorders, depending on the type of medications : their respective metabolic effects will be analyzed in a next article.</p>","PeriodicalId":21414,"journal":{"name":"Revue medicale de Liege","volume":"78 4","pages":"199-203"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue medicale de Liege","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Metabolic disorders, especially obesity, type 2 diabetes and metabolic syndrome, are frequently associated with depressive symptomatology, including severe depression. In fact, there is a two-way relationship : metabolic disorders could promote depression and depression could favour metabolic disorders, which may lead to a vicious circle. The reasons for this astonishing relationship are diverse : a genetic predisposition, shared biochemical abnormalities including low-grade inflammation, bad habits that combine unhealthy food and excessive sedentary life-style, poor therapeutic compliance. Medications that target metabolic disorders may positively impact depression, with recent promising, yet preliminary, data with glucagon-like peptide-1 receptor agonists. Moreover, antidepressants may also influence metabolic disorders, depending on the type of medications : their respective metabolic effects will be analyzed in a next article.